Reply to 'LMP2 expression and proteasome activity in NOD mice'

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Nature Medicine

• Publication date

  2000-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/80353PMID 11017113
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids

  2004cited by this paper
• NOD Mice Are Defective in Proteasome Production and Activation of NF-κB

  1999cited by this paper
• NOD mice are defective in proteasome production and activation of NF-kappaB.

  1999cited by this paper
• NF-κB p105 Processing via the Ubiquitin-Proteasome Pathway*

  1998cited by this paper
• Substrate binding and sequence preference of the proteasome revealed by active-site-directed affinity probes.

  1998cited by this paper
• Mutations in the Yeast Proteasome β-Type Subunit Pre3 Uncover Position-dependent Effects on Proteasomal Peptidase Activity and in Vivo Function*

  1998cited by this paper
• Immunoproteasome Assembly: Cooperative Incorporation of Interferon γ (IFN-γ)–inducible Subunits

  1998cited by this paper
• Intermediates in the formation of mouse 20S proteasomes: implications for the assembly of precursor beta subunits.

  1997cited by this paper
• Protection of NIT-1 pancreatic beta-cells from immune attack by inhibition of NF-kappaB.

  1997cited by this paper
• Immunoproteasome Assembly : Cooperative Incorporation of Interferon g ( IFN-g ) – inducible Subunits

  1997cited by this paper
• Reduced expression of Tap1 and Lmp2 antigen-processing genes in the nonobese diabetic (NOD) mouse due to a mutation in their shared bidirectional promoter.

  1997cited by this paper
• Intermediates in the formation of mouse 20S proteasomes: implications for the assembly of precursor β subunits

  1997cited by this paper
• Proteasomes and antigen processing.

  1997cited by this paper
• Protection of NIT-1 Pancreatic β-Cells From Immune Attack by Inhibition of NF-κB

  1997cited by this paper
• Molecular and serological analysis of polymorphisms in the murine major histocompatibility complex-encoded proteasome subunits, LMP-2 and LMP-7.

  1996cited by this paper
• Multifactorial inheritance in type 1 diabetes.

  1995cited by this paper
• Altered peptidase and viral-specific T cell response in LMP2 mutant mice.

  1994cited by this paper
• The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B.

  1994cited by this paper
• Type-I diabetes: a chronic autoimmune disease of human, mouse, and rat.

  1990cited by this paper
• Breeding of a non-obese, diabetic strain of mice.

  1980cited by this paper

• Spontaneous Myocarditis in Mice Predisposed to Autoimmune Disease: Including Vaccination-Induced Onset

  2022cites this paper
• Targeting immunoproteasome in neurodegeneration: A glance to the future.

  2022cites this paper
• Oncological Properties of Intravenous Leiomyomatosis: Involvement of Mesenchymal Tumor Stem-Like Cells

  2021cites this paper
• Molecular pathological approach of uterine intravenous leiomyomatosis

  2021cites this paper
• Immunoproteasome Upregulation Is Not Required to Control Protein Homeostasis during Viral Infection

  2021cites this paper
• Diagnostic Biomarker Candidates Including NT5DC2 for Human Uterine Mesenchymal Tumors

  2021cites this paper
• Candidate molecules as diagnostic biomarker for human uterine mesenchymal tumors

  2020cites this paper
• Immunoproteasome Function in Lymphocyte Activation

  2019cites this paper
• Elucidating proteasome catalytic subunit composition and its role in proteasome inhibitor resistance

  2016cites this paper
• Université de Montréal-Thèse numérique

  2016cites this paper
• Biological characterization of soft tissue sarcomas.

  2015cites this paper
• The immunoproteasome and viral infection: a complex regulator of inflammation

  2015cites this paper
• Molecular Approaches for Understanding of the Uterine Malignant Mesenchymal Tumours

  2015cites this paper
• Why Test BCG in Sjögren’s Syndrome?

  2014cites this paper
• Potential Diagnostic Biomarkers: Differential Expression of LMP2/β1i and Cyclin B1 in Human Uterine Leiomyosarcoma

  2014cites this paper
• TNF, BCG, and the Proteasome in Autoimmunity: An Overview of the Pathways & Results of a Phase I Study in Type 1 Diabetes

  2014cites this paper
• TNF Receptor 2 and Disease: Autoimmunity and Regenerative Medicine

  2013cites this paper
• Inhibitors of the immunoproteasome: current status and future directions.

  2013cites this paper
• EBV infection and anti-CD3 treatment for Type 1 diabetes: bad cop, good cop?

  2013cites this paper
• Proof-of-Concept, Randomized, Controlled Clinical Trial of Bacillus-Calmette-Guerin for Treatment of Long-Term Type 1 Diabetes

  2012cites this paper
• Immunoproteasomes at the interface of innate and adaptive immune responses: two faces of one enzyme.

  2012cites this paper
• Revisiting the role of the immunoproteasome in the activation of the canonical NF-κB pathway.

  2012cites this paper
• Unexpected Finding of Biological Phenomenon :∼Biological Characteristics of Uterine Leiomyosarcoma∼

  2012cites this paper
• A selective inhibitor of the immunoproteasome subunit LMP2 induces apoptosis in PC-3 cells and suppresses tumour growth in nude mice

  2012cites this paper
• Target validation of UK-101 and functional studies of beta1i

  2011cites this paper
• Pancreatic β-Cells Regeneration During the Reversal of Autoimmune Diabetes in Nod Mice.

  2011cites this paper
• TNF receptor 2 pathway: drug target for autoimmune diseases

  2010cites this paper
• Immunoproteasome Overexpression Underlies the Pathogenesis of Thyroid Oncocytes and Primary Hypothyroidism: Studies in Humans and Mice

  2009cites this paper
• Selective death of autoreactive T cells in human diabetes by TNF or TNF receptor 2 agonism

  2008cites this paper
• The therapeutic potential of tumor necrosis factor for autoimmune disease: a mechanistically based hypothesis

  2005cites this paper
• Methods to characterize lymphoid apoptosis in a murine model of autoreactivity.

  2005cites this paper
• Role of defective apoptosis in type 1 diabetes and other autoimmune diseases.

  2003cites this paper
• Islet Regeneration During the Reversal of Autoimmune Diabetes in NOD Mice

  2003cites this paper
• Diabetes Therapeutics News

  2002cites this paper
• T-cell education in autoimmune diabetes: teachers and students.

  2002cites this paper
• Reversal of established autoimmune diabetes by restoration of endogenous β cell function

  2001cites this paper
• Selected contribution: Association of gender-related LMP2 inactivation with autoimmune pathogenesis.

  2001cites this paper